myo51 Antibody

What is Myo51 and why are antibodies against it important for cytoskeletal research?

Myo51 is a myosin-V motor protein that affects contractile ring assembly and stability during fission yeast cytokinesis. It plays dual roles in both early contractile ring assembly and late stages of cytokinesis . Antibodies against Myo51 are crucial for studying actin-based motor proteins and their functions in cytoskeletal dynamics, particularly during cell division. These antibodies enable researchers to visualize Myo51 localization patterns, identify protein-protein interactions, and investigate the protein's role in actin filament organization.

When selecting Myo51 antibodies for cytoskeletal research, consider the specific domains you wish to target. The rod region in Myo51's tail (approximately aa 903-1078) is essential for its localization and function , making antibodies targeting this domain particularly valuable for localization studies.

What detection methods work best with Myo51 antibodies in fission yeast?

For optimal detection of Myo51 in fission yeast, the following methodologies have proven most effective:

For immunofluorescence, consider dual staining with actin markers to observe co-localization patterns, particularly at the division site where Myo51 forms a meshwork between Rlc1-labeled cytokinesis nodes .

How can I validate the specificity of a Myo51 antibody?

Validating Myo51 antibody specificity requires multiple complementary approaches:

• Genetic validation: Test antibody in wild-type and myo51Δ strains. A specific antibody will show signal in wild-type cells but not in the deletion mutant.

• Western blot analysis: Look for a single band at approximately 254.4 kDa (the expected molecular weight of Myo51). Multiple bands may indicate degradation products or cross-reactivity.

• Immunoprecipitation followed by mass spectrometry: This can confirm that the antibody is capturing Myo51 and identify any cross-reacting proteins.

• Peptide competition assay: Pre-incubate the antibody with purified Myo51 peptide before application. A specific antibody will show diminished or absent signal.

• Cross-species reactivity testing: If you need an antibody that works across species, test against Myo51 homologs from different organisms.

The antibody should recognize Myo51 in its native locations, including cytoplasmic puncta during interphase and at the division site during cytokinesis .

How can I use Myo51 antibodies to study the relationship between Myo51 and the Rng8-Rng9 complex?

The Rng8-Rng9 complex is essential for proper Myo51 localization and function . To study this relationship:

• Co-immunoprecipitation studies: Use Myo51 antibodies to pull down the protein complex and blot for Rng8 and Rng9. Focus on antibodies targeting the rod region of Myo51 (aa 903-1078), as this region is critical for interaction with the Rng8-Rng9 complex .

• Proximity ligation assays: This technique can visualize the direct interaction between Myo51 and Rng8-Rng9 in situ, providing spatial information about where these interactions occur within the cell.

• Immunofluorescence in genetic backgrounds: Compare Myo51 localization in wild-type, rng8Δ, and rng9Δ cells. In wild-type cells, each Myo51 punctum contains approximately 9.7 ± 4.9 Myo51 molecules, 15.5 ± 8.0 Rng8 molecules, and 17.4 ± 8.4 Rng9 molecules, suggesting a stoichiometry of ~2:2:1 (Rng8:Rng9:Myo51) .

• Domain mapping: Use antibodies recognizing specific Myo51 domains to determine which regions are masked or exposed when bound to the Rng8-Rng9 complex.

This multimodal approach will provide comprehensive insights into how the Rng8-Rng9 complex regulates Myo51 clustering and function.

What are the methodological considerations when using Myo51 antibodies for live-cell imaging?

While fixed-cell immunofluorescence with Myo51 antibodies provides valuable snapshots, studying Myo51 dynamics often requires live-cell approaches. Consider these methodological alternatives and complementary strategies:

• Fluorescently tagged Myo51: Instead of antibodies, genomically tag Myo51 with GFP or mCherry. Verify that the tag doesn't interfere with the protein's function by comparing with antibody staining patterns.

• Antibody fragment (Fab) microinjection: For direct antibody visualization in live cells, consider using fluorescently labeled Fab fragments. This approach requires:

  • Generating and purifying Fab fragments from Myo51 antibodies

  • Fluorescent labeling with minimal impact on antigen recognition

  • Microinjection into live cells using techniques similar to those described for Acanthamoeba studies

  • Careful titration to avoid functional inhibition

• Combined approaches: For the most comprehensive analysis, perform live imaging followed by fixation and antibody staining of the same cells to correlate dynamic and static observations.

When analyzing Myo51 dynamics, pay particular attention to its behavior during contractile ring assembly and constriction, where it plays important roles in actin organization and stability .

How can I use Myo51 antibodies to investigate the motor-independent functions of Myo51?

Myo51 has both motor-dependent and motor-independent functions in cytokinesis . To specifically investigate the motor-independent functions:

• Domain-specific antibodies: Use antibodies targeting different domains of Myo51 to distinguish between motor and tail functions. Antibodies against the rod region (aa 903-1078) are particularly valuable as this region is essential for localization .

• Genetic-antibody combined approach: In cells expressing truncated Myo51 lacking the motor domain, use antibodies to track the localization and interactions of the tailless protein. Compare these results with full-length Myo51.

• Functional blocking studies: Similar to the approach with myosin-II antibodies , microinject Myo51 antibodies that specifically bind different domains to selectively block functions. Compare the effects of antibodies that inhibit motor activity versus those that don't.

• Co-immunoprecipitation in different genetic backgrounds: Use Myo51 antibodies for pull-downs in wild-type cells versus myp2Δ (myosin-II deletion) cells to identify differential protein interactions that might explain the synthetic effects observed in myo51Δ myp2Δ double mutants .

These approaches will help dissect the molecular mechanisms underlying the observation that Myo51's role in late cytokinesis is likely motor-independent but still requires the Rng8-Rng9 complex .

Why might I observe non-specific staining with my Myo51 antibody?

Non-specific staining with Myo51 antibodies can arise from several sources:

For definitive confirmation of antibody specificity, always include a myo51Δ strain as a negative control. Any signal detected in these cells represents non-specific binding.

How can I optimize antibody conditions for detecting Myo51's transient localization during cytokinesis?

Myo51 shows dynamic localization during cytokinesis, forming a meshwork between Rlc1-labeled nodes during contractile ring assembly . To capture these transient structures:

• Synchronize cell populations: Use cell cycle synchronization methods to enrich for cells in cytokinesis.

• Time-course fixation: Fix cells at short intervals (2-5 minutes) throughout cytokinesis to capture all transitional states.

• Co-staining optimization:

  • Use Rlc1 markers to identify cytokinesis nodes

  • Include actin staining to visualize the relationship between Myo51 and actin structures

  • Consider triple staining with Rng8 or Rng9 antibodies

• Signal amplification techniques:

  • Tyramide signal amplification can enhance detection of low-abundance or transiently localized proteins

  • Quantum dot-conjugated secondary antibodies provide higher sensitivity

• Imaging parameters:

  • Use deconvolution microscopy or super-resolution techniques for better resolution of fine structures

  • Optimize exposure times to capture weak signals without bleaching

Remember that Myo51 puncta contain approximately 9.7 ± 4.9 molecules per punctum , so detection methods must be sensitive enough for these relatively small clusters.

How can I use Myo51 antibodies to investigate the role of Myo51 in actin cable organization?

Myo51 affects actin cable organization and dynamics during cytokinesis . To investigate this role:

• Dual immunofluorescence: Combine Myo51 antibodies with actin staining to visualize their spatial relationship. In myo51Δ cells, the actin meshwork at the division site is more disorganized .

• Quantitative analysis techniques:

  • Measure cable orientation and curvature in wild-type versus myo51Δ cells

  • Classify cables as properly oriented or misoriented

  • Quantify the frequency of curved cables

• Pharmacological approaches:

  • Treat cells with Arp2/3 inhibitors to reduce interference from actin patches

  • Follow with fixation and dual staining for Myo51 and actin

• Live-cell imaging followed by antibody staining:

  • Track actin dynamics in live cells

  • Fix the same cells and perform antibody staining

  • Correlate dynamic behavior with protein localization

In wild-type cells, Myo51 helps organize actin cables and stabilizes the contractile ring. In myo51Δ cells, misoriented and curved cables increase significantly during both interphase and cytokinesis .

What techniques should I use when studying synthetic genetic interactions involving Myo51?

Myo51 shows synthetic genetic interactions with myp2Δ (myosin-II deletion) and ain1Δ (α-actinin deletion) . When investigating these interactions:

• Immunofluorescence in genetic backgrounds:

  • Compare Myo51 localization in wild-type, myp2Δ, and ain1Δ cells

  • Use antibodies against the contractile ring (Rlc1) and plasma membrane (Psy1) to assess ring integrity in double mutants

• Quantitative phenotypic analysis:

  • Measure septation defects in single versus double mutants

  • Quantify contractile ring stability and constriction rates

• Domain-specific studies:

  • Use antibodies against specific Myo51 domains in different genetic backgrounds

  • Determine which domains are critical for the synthetic interactions

• Rescue experiments:

  • Express Myo51 truncations in myo51Δ myp2Δ cells

  • Use antibodies to confirm expression and localization

  • Assess whether specific domains can rescue the synthetic phenotype

These approaches will help determine the molecular basis for the observation that Myo51's role in late cytokinesis is motor-independent but shows strong genetic interactions with myp2Δ .

How can I develop quantitative imaging approaches using Myo51 antibodies?

For quantitative analysis of Myo51 using antibody-based imaging:

• Calibrated fluorescence measurements:

  • Use purified, fluorescently labeled antibodies at known concentrations

  • Create standard curves with purified Myo51 protein

  • Apply this calibration to cellular measurements

• Single-molecule detection:

  • Super-resolution techniques like STORM or PALM

  • Directly count Myo51 molecules in cellular structures

• Cluster analysis protocols:

  • Measure size, intensity, and distribution of Myo51 puncta

  • Compare to known values (9.7 ± 4.9 Myo51 molecules per punctum)

  • Analyze cluster size distribution in different genetic backgrounds

• Colocalization quantification:

  • Pearson's correlation coefficient between Myo51 and actin structures

  • Manders' overlap coefficient for Myo51 and Rng8/Rng9

• Photobleaching approaches:

  • Combine with GFP-tagged Myo51

  • Correlate antibody signal intensity with absolute molecule numbers

These quantitative approaches will enable precise measurement of how Myo51 organization changes in different genetic backgrounds or experimental conditions.

How might Myo51 antibodies be used in comparative studies across myosin family members?

While Myo51 has been primarily studied in fission yeast, comparative analysis across myosin family members can provide evolutionary insights:

• Cross-reactivity testing:

  • Determine if Myo51 antibodies recognize homologous proteins in other species

  • Map conserved epitopes across myosin family members

• Comparative localization studies:

  • Use antibodies against different myosins in the same cells

  • Determine unique versus overlapping functions

• Domain-specific comparative analysis:

  • Focus on antibodies against the rod region (aa 903-1078) of Myo51

  • Compare with equivalent regions in other myosins

  • Investigate whether these regions serve similar localization functions

• Functional complementation approaches:

  • Express myosins from other species in myo51Δ cells

  • Use antibodies to confirm expression and localization

  • Determine which functions are conserved

This research direction could help determine whether the mechanism by which the Rng8-Rng9 complex regulates Myo51 is conserved for other myosin-V proteins across species.

What considerations are important when generating new Myo51 antibodies for specialized applications?

When developing new Myo51 antibodies for specific research applications:

• Epitope selection strategies:

  • Target the rod region (aa 903-1078) for localization studies

  • Choose motor domain epitopes for functional studies

  • Select unique sequences with low homology to other myosins

• Antibody format considerations:

  • Monoclonal antibodies for consistent results and specificity

  • Polyclonal antibodies for robust detection

  • Recombinant antibodies for reproducibility

  • Nanobodies for live-cell applications

• Validation requirements:

  • Test in wild-type and myo51Δ cells

  • Verify epitope accessibility in fixed versus native conditions

  • Check for interference with Myo51 function

• Application-specific modifications:

  • Site-specific fluorescent labeling for quantitative imaging

  • Enzyme conjugation for proximity labeling

  • Cleavable crosslinkers for specialized pull-down experiments

These considerations will help researchers develop next-generation antibody tools for studying the complex roles of Myo51 in cytokinesis and actin organization.